About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Alembic Pharmaceuticals Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
533573
ISIN Demat
INE901L01018
Book Value
264.28
NSE Code
APLLTD
Dividend Yield %
1.07
Market Cap
201909.64
P/E
40.13
EPS
25.60
Face Value
2
BSE
NSE
01-Jul-2025 10:16
BSE
NSE
NSE F & O
01-Jul-2025 10:09
BSE
NSE
NSE F & O
Last Price
1026.85
Net Change
-15.75
% Change
-1.51%
Prev.Close
1042.60
Open
1028.15
High
1050.00
Low
1022.95
Volume
34183
Last Price
1027.90
Net Change
-11.2
% Change
-1.08%
Prev.Close
1039.10
Open
1024.80
High
1051.70
Low
1021.90
Volume
347576
Value
35100813.55
Best Buy
1025.85
Best Sell
1027.85
Best Quantity
54
Sell Quantity
41
Today's Range
1050.00
52-Week High
1296.15
52-Week Low
725.60
Value
357273370.4
Best Buy
1027.20
Best Sell
1028.00
Best Quantity
22
Sell Quantity
7
Today's Range
1051.70
52-Week High
1303.90
52-Week Low
725.20
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
54
Price
1025.85
Quantity
41
Price
1027.85
Best Bid
Best Offer
Quantity
22
Price
1027.20
Quantity
7
Price
1028.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
21-Jul-21
27-Jul-21
Dividend
550 %
29-Jul-25
Company News
30-06-2025
Alembic Pharmaceuticals g...
30-06-2025
Alembic Pharmaceuticals z...
18-06-2025
Alembic Pharmaceuticals g...
02-06-2025
USFDA concludes inspectio...
31-05-2025
Alembic Pharmaceuticals r...
23-05-2025
Alembic Pharmaceuticals g...
15-05-2025
Alembic Pharmaceuticals g...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
